{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001410098","name":"CorMedix Inc.","summary":"CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases. Its primary product, DefenCath (taurolidine and heparin), is the first FDA-approved antimicrobial catheter lock solution for reducing catheter-related bloodstream infections in hemodialysis patients. Following its August 2025 acquisition of Melinta Therapeutics, the company expanded its portfolio to include six hospital-focused anti-infective products and one cardiovascular product.","people":[],"products":[{"name":"DefenCath (taurolidine and heparin)","type":"service","description":"FDA-approved antimicrobial catheter lock solution to reduce CRBSI incidence in adult hemodialysis patients with kidney failure using a central venous catheter."},{"name":"REZZAYO (rezafungin for injection)","type":"service","description":"Marketed anti-infective for serious fungal infections; also being studied for prophylaxis in immunocompromised patients."},{"name":"MINOCIN IV (minocycline for injection)","type":"service","description":"Hospital-focused injectable anti-infective for serious bacterial infections."},{"name":"VABOMERE (meropenem and vaborbactam)","type":"service","description":"Hospital-focused anti-infective for serious gram-negative bacterial infections."},{"name":"KIMYRSA (oritavancin)","type":"service","description":"Anti-infective for serious gram-positive infections in hospital and clinic settings."},{"name":"ORBACTIV (oritavancin)","type":"service","description":"Anti-infective for serious gram-positive infections in hospital and clinic settings."},{"name":"BAXDELA (delafloxacin)","type":"service","description":"Anti-infective for serious bacterial infections in hospital and clinic settings."},{"name":"TOPROL-XL (metoprolol succinate)","type":"service","description":"Established cardiovascular product acquired as part of the Melinta Therapeutics portfolio."}],"partnerships":[{"partner_name":"Large and mid-sized dialysis organizations (unnamed)","partnership_type":"strategic","description":"Multi-year commercial supply agreements covering roughly 60% of U.S. outpatient dialysis centers by addressable patient market.","start_date":null}],"affiliations":[],"origin":{"leaf":"af4e3408d1ef62eae5e5828cce3fd8b30e8d4c95db28ed284a6f097b2faefa1b","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"33413a92b20dbee0aa5ccbb309474147f8aefdfa7dea6452c8c840a6310d5b30","parent":"66cb02f2656ab6e207760ebe125c9a16415af0525c60e26fc7947cfc687e0830","source":"0001213900-26-023889","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":500,"hourly_limit":500,"remaining":0,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}